Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Relationship between plasma concentrations of lamotrigine and its early therapeutic effect of lamotrigine augmentation therapy in treatment-resistant depressive disorder.

Kagawa S, Mihara K, Nakamura A, Nemoto K, Suzuki T, Nagai G, Kondo T.

Ther Drug Monit. 2014 Dec;36(6):730-3. doi: 10.1097/FTD.0000000000000088.

PMID:
24819973
2.

Prediction of an Optimal Dose of Lamotrigine for Augmentation Therapy in Treatment-Resistant Depressive Disorder From Plasma Lamotrigine Concentration at Week 2.

Nakamura A, Mihara K, Nagai G, Kagawa S, Suzuki T, Nemoto K, Kondo T.

Ther Drug Monit. 2016 Jun;38(3):379-82. doi: 10.1097/FTD.0000000000000279.

PMID:
26829597
3.

A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.

Barbee JG, Thompson TR, Jamhour NJ, Stewart JW, Conrad EJ, Reimherr FW, Thompson PM, Shelton RC.

J Clin Psychiatry. 2011 Oct;72(10):1405-12. doi: 10.4088/JCP.09m05355gre.

PMID:
21367355
4.

Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.

Ivković M, Damjanović A, Jovanović A, Cvetić T, Jasović-Gasić M.

Psychiatr Danub. 2009 Jun;21(2):187-93.

5.

[Augmentation of antidepressants with unsaturated fatty acids omega-3 in drug-resistant depression].

Krawczyk K, Rybakowski J.

Psychiatr Pol. 2012 Jul-Aug;46(4):585-98. Polish.

PMID:
23214161
6.

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

J Clin Psychiatry. 2009 Feb;70(2):223-31. Epub 2008 Dec 30.

PMID:
19200421
8.

Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.

Bauer M, Dell'osso L, Kasper S, Pitchot W, Dencker Vansvik E, Köhler J, Jørgensen L, Montgomery SA.

J Affect Disord. 2013 Oct;151(1):209-19. doi: 10.1016/j.jad.2013.05.079. Epub 2013 Jun 27.

PMID:
23810357
9.

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD.

J Clin Psychiatry. 1999 Feb;60(2):79-88.

PMID:
10084633
10.
11.

A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.

McElroy SL, Zarate CA, Cookson J, Suppes T, Huffman RF, Greene P, Ascher J.

J Clin Psychiatry. 2004 Feb;65(2):204-10.

PMID:
15003074
12.

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J; Lamictal 605 Study Group.

J Clin Psychiatry. 2003 Sep;64(9):1013-24.

PMID:
14628976
13.

A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.

Cusin C, Iovieno N, Iosifescu DV, Nierenberg AA, Fava M, Rush AJ, Perlis RH.

J Clin Psychiatry. 2013 Jul;74(7):e636-41. doi: 10.4088/JCP.12m08093.

PMID:
23945458
14.

Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study.

Schindler F, Anghelescu IG.

Int Clin Psychopharmacol. 2007 May;22(3):179-82.

PMID:
17414745
15.

Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.

Kemp DE, Gao K, Fein EB, Chan PK, Conroy C, Obral S, Ganocy SJ, Calabrese JR.

Bipolar Disord. 2012 Nov;14(7):780-9. doi: 10.1111/bdi.12013.

16.

Lamotrigine in rapid-cycling bipolar disorder.

Fatemi SH, Rapport DJ, Calabrese JR, Thuras P.

J Clin Psychiatry. 1997 Dec;58(12):522-7.

PMID:
9448654
17.

Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament.

Manning JS, Haykal RF, Connor PD, Cunningham PD, Jackson WC, Long S.

J Affect Disord. 2005 Feb;84(2-3):259-66.

PMID:
15708424
18.

A factor analytic study in bipolar depression, and response to lamotrigine.

Mitchell PB, Hadzi-Pavlovic D, Evoniuk G, Calabrese JR, Bowden CL.

CNS Spectr. 2013 Aug;18(4):214-24. doi: 10.1017/S1092852913000291. Epub 2013 May 23.

PMID:
23702258
19.
20.

Lamotrigine as an augmentation agent in treatment-resistant depression.

Barbee JG, Jamhour NJ.

J Clin Psychiatry. 2002 Aug;63(8):737-41.

PMID:
12197456

Supplemental Content

Support Center